Latest Stem cell Stories

Dr. Wayne Marasco to Talk at "Second International Vatican Adult Stem Cell Conference" JUPITER, Fla., April 9, 2013 /PRNewswire/ -- BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTCBB: BRTX), a life sciences company focused on adult stem cell based cellular therapies for various personal medical applications, announced today that Wayne Marasco, M.D., Ph.D., Chairman of BRT's Scientific Advisory Board, will be speaking at the Second International Vatican Adult Stem Cell...

Rejuv Medical, a sports medicine company based out of Minnesota, is now offering stem cell treatments to the company’s clientele. Minnesota (PRWEB) April 08, 2013 Rejuv Medical is based in Minnesota. The company specializes in orthopedic and physical therapy services under doctor Joel Baumgartner’s care. Now, the company is providing stem cell treatments to clients seeking an alternative to surgery or who need a second opinion about a medical condition. More information can be...

Stem Cell Orthopedic Applauds New Study Showing Platelet Rich Plasma Therapy Significantly Improving Clinical Results in Patients with Tennis Elbow. (PRWEB) April 06, 2013 StemCellOrthopedic.com, popular website of the Institute of Regenerative and Molecular Orthopaedics (IRMO), world renowned stem cell therapy experts, applauds a recent study displaying the efficacy of platelet rich plasma (PRP) therapy in treating patients with tennis elbow. This study comes on the heels of a wave of...

A recent Harper's Bazaar article discusses a new skin care treatment that utilizes one's own stem cells to eliminate the visual signs of aging. Dr. Simon Ourian of Epione Beverly Hills says there needs to be more research done before he’d offer the treatment to his patients. Los Angeles, California (PRWEB) April 06, 2013 According to a recent Harper’s Bazaar article, stem cells have been discovered to offer effective anti-aging properties. A new skin care company is offering a...

Alan McStravick for redOrbit.com - Your Universe Online Until recently, scientists believed that the nerve cells in the brain associated with appetite regulation were generated entirely during embryonic development. This meant if you were pre-programmed for an eating disorder, the nerve cells were fixed for life. However, a team of researchers at the University of East Anglia (UEA) in the UK have made a breakthrough in the field of neurosciences which could offer a long-lasting...

[Watch the Video: Engineering Blood Vessels ] redOrbit Staff & Wire Reports - Your Universe Online Researchers from the University of Michigan (UM) have reportedly discovered a way to overcome one of the primary obstacles to growing replacement hearts, lungs, kidneys and other new organs. Those replacement organs often fail because of the difficulties associated with building blood vessels in order to keep their tissues alive. Now UM associate biomedical engineering professor...

ROCKVILLE, Md., April 5, 2013 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced today that it received a notice of allowance for patent application 12/404,841. This patent covers methods for treating amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) with expanded spinal cord stem cells, including NSI-566. Neuralstem completed a Phase I safety trial of its NSI-566 stem cells in ALS earlier this year, for which it has also been granted an Orphan Drug Designation. The...

April Flowers for redOrbit.com - Your Universe Online A new study from the University of California, San Francisco (UCSF) reveals that treating patients with cells may one day become as common as it is now to treat the sick with drugs from engineered proteins, antibodies, or smaller chemicals. The team outlines their vision of cell-based therapy as a "third pillar of medicine" in an online edition of Science Translational Medicine. "Today, biomedical science sits on the cusp of a...

Dr. Saud A. Sadiq to Discuss Cellular Therapy for MS at the Second International Adult Stem Cell Conference: Regenerative Medicine – A Fundamental Shift in Science and Culture. New York, NY (PRWEB) April 03, 2013 The Tisch MS Research Center of New York announced today that Dr. Saud A. Sadiq has accepted an invitation to participate in the Second International Adult Stem Cell Conference: Regenerative Medicine - A Fundamental Shift in Science and Culture to be held within the Vatican,...

PALO ALTO, Calif., April 3, 2013 /PRNewswire/ -- This week Cellular Biomedicine Group (OTCQB: CBMG) held a ceremony to mark the launch of their clinical trial for haMPC (Human Adipose-derived Mesenchymal Progenitor Cells) therapy for Knee Osteoarthritis (KOA). The trial, already in progress, is being conducted by Shanghai's Renji Hospital, which is a tertiary level Class A hospital affiliated to Shanghai Jiao Tong University School of Medicine. The Phase I open label clinical...